Clarity Pharmaceuticals (ASX:CU6) Expands Radiopharmaceutical Pipeline
Clarity Pharmaceuticals (ASX:CU6) unveils a novel radiopharmaceutical, SAR-bisFAP, enhancing cancer diagnosis and treatment potential.
Clarity Pharmaceuticals (ASX:CU6) unveils a novel radiopharmaceutical, SAR-bisFAP, enhancing cancer diagnosis and treatment potential.
Carbonxt Group Limited (ASX:CG1) has achieved mechanical completion of its Kentucky plant, enhancing its capacity to meet activated carbon market demand.
Adisyn Ltd has completed due diligence for acquiring 2D Generation, enhancing its semiconductor technology capabilities for the generative AI market.
MetalsTech Limited (ASX:MTC) provides updates on the Sturec Gold Mine’s operations, maintenance, and identified mineralisation potential.
MONEYME secures a strategic A$125 million funding facility with iPartners, enhancing growth and refinancing existing debt.
Triangle Energy (ASX:TEG) reports the first payment for the Cliff Head project sale remains unpaid, creating immediate financial implications.
Skin Elements Limited (ASX:SKN) has requested a trading halt pending significant announcements regarding a court application and capital raising.
Viva Leisure (ASX:VVA) secures a Master Franchise Agreement in the UK, expanding the Plus Fitness brand amidst notable market opportunities.
BPH Global commits A$100,000 funding for its Indonesian seaweed venture through convertible notes.
Godolphin Resources (ASX:GRL) announces significant drill results, enhancing mineral resource potential at its Lewis Ponds project.